Summary & Overview
HCPCS J0780: Prochlorperazine Injection, up to 10 mg
HCPCS Level II code J0780 denotes administration of prochlorperazine injection, up to 10 mg. This single-drug HCPCS code is relevant across acute and ambulatory care settings for management of nausea and vomiting and certain behavioral or psychotic presentations requiring parenteral therapy. Nationally, accurate coding of injectable antiemetics affects claims processing, drug utilization tracking, and quality measurement tied to emergency and inpatient care.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for injectable prochlorperazine, typical sites of service where J0780 is billed, and the common modifiers associated with injectable drug administration. The publication summarizes billing benchmarks and reimbursement considerations, highlights relevant billing practice observations, and outlines coding nuances that influence claim adjudication. It also identifies gaps where input data are not available.
The piece serves clinicians, billing professionals, and policy analysts seeking concise guidance on the role of HCPCS Level II code J0780 in reimbursement workflows, utilization reporting, and clinical documentation for parenteral antiemetic therapy.
Billing Code Overview
HCPCS Level II code J0780 represents an injection of prochlorperazine, up to 10 mg. This code is used for single-dose injectable administration of prochlorperazine, an antiemetic and antipsychotic commonly used for nausea and vomiting and certain acute agitation or psychotic symptoms when administered parenterally.
-
Service type: Injectable medication administration
-
Typical site of service: Ambulatory clinics, emergency departments, urgent care centers, and inpatient hospital settings where parenteral antiemetic therapy is provided
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient in the emergency department presents with acute nausea and intractable vomiting after a migraine or gastroenteritis. After triage and evaluation, intravenous antiemetic therapy is ordered. The clinician documents the indication, reviews allergies and medication history, and obtains informed consent for parenteral medication administration. A registered nurse prepares and administers J0780 (injection, prochlorperazine, up to 10 mg) either intramuscularly or intravenously per facility protocol. The patient is monitored for therapeutic response and adverse effects (extrapyramidal symptoms, hypotension, sedation). If additional supportive care is needed, IV fluids and analgesics may be given; if severe dystonia occurs, diphenhydramine or benztropine is administered. The encounter note includes the drug name, dose, route, time of administration, lot number if required, and any immediate reaction. Billing uses J0780 for the medication and appropriate service-level CPT codes for the ED or clinic visit and procedures performed during the same encounter.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of procedure | Use when a distinct E/M visit is documented in addition to administration of in an office or clinic setting |